Literature DB >> 15547084

Health status of patients with ankylosing spondylitis: a comparison with the general population.

H Dagfinrud1, A M Mengshoel, K B Hagen, J H Loge, T K Kvien.   

Abstract

OBJECTIVE: To examine the subjective health in patients with ankylosing spondylitis (AS) compared with the general population, and to explore the associations between health status and age, sex of the patients, and educational level in AS.
METHODS: Health status was assessed with a generic instrument (SF-36) in 314 patients with AS and in 2323 people from the general population. Subgroup analyses were performed according to age, sex, and educational level. Standard difference scores (s-scores) were calculated to ensure the clinical meaningfulness of the norm based comparisons.
RESULTS: Both men and women with AS reported significantly impaired health on all scales of the SF-36. Women reported significantly worse health on physical health domains. However, when calculating differences from the general population, numerically larger s-scores were found for men (except for physical role and vitality). The relative impact of AS seems to diminish with increasing age. In AS, better health was significantly associated with higher education across all scales. Deviations from the general population on the non-physical health aspects were especially pronounced in patients with low education.
CONCLUSIONS: All key dimensions of health are affected by AS. The physical aspects seem to be most severely affected, but in the less educated group of patients, the disease impact on the mental health aspects was also considerable. Evaluation and management planning should take the complexity of AS into consideration. The focus on physical function should be maintained, and additional attention should be paid to the mental and social consequences of AS.

Entities:  

Mesh:

Year:  2004        PMID: 15547084      PMCID: PMC1754848          DOI: 10.1136/ard.2003.019224

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  36 in total

1.  Use of the SF-36 and other health-related quality of life measures to assess persons with disabilities.

Authors:  Ron D Hays; Harlan Hahn; Grant Marshall
Journal:  Arch Phys Med Rehabil       Date:  2002-12       Impact factor: 3.966

2.  Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.

Authors:  L C Doward; A Spoorenberg; S A Cook; D Whalley; P S Helliwell; L J Kay; S P McKenna; A Tennant; D van der Heijde; M A Chamberlain
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

3.  Methotrexate in the treatment of ankylosing spondylitis.

Authors:  R W Marshall; J R Kirwan
Journal:  Scand J Rheumatol       Date:  2001       Impact factor: 3.641

Review 4.  New criteria for the diagnosis of ankylosing spondylitis.

Authors:  J M Moll
Journal:  Scand J Rheumatol Suppl       Date:  1987

5.  The natural disease course of ankylosing spondylitis.

Authors:  S Carette; D Graham; H Little; J Rubenstein; P Rosen
Journal:  Arthritis Rheum       Date:  1983-02

6.  Radiologic changes of cervical spine in ankylosing spondylitis.

Authors:  H S Lee; T H Kim; H R Yun; Y W Park; S S Jung; S C Bae; K B Joo; S Y Kim
Journal:  Clin Rheumatol       Date:  2001       Impact factor: 2.980

7.  Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis.

Authors:  Rafael Ariza-Ariza; Blanca Hernández-Cruz; Federico Navarro-Sarabia
Journal:  Arthritis Rheum       Date:  2003-08-15

8.  Ankylosing spondylitis in men and women: a clinical and radiographic comparison.

Authors:  E M Braunstein; W Martel; R Moidel
Journal:  Radiology       Date:  1982-07       Impact factor: 11.105

Review 9.  Biologic therapies in the spondyloarthritis: new opportunities, new challenges.

Authors:  Juergen Braun; Jan Brandt; Joachim Listing; Martin Rudwaleit; Joachim Sieper
Journal:  Curr Opin Rheumatol       Date:  2003-07       Impact factor: 5.006

10.  Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.

Authors:  J Brandt; A Khariouzov; J Listing; H Haibel; H Sörensen; L Grassnickel; M Rudwaleit; J Sieper; J Braun
Journal:  Arthritis Rheum       Date:  2003-06
View more
  53 in total

1.  Health-related quality of life in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2010-10-31       Impact factor: 2.980

2.  Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

Authors:  Zrinka Jajić; Ivana Rajnpreht; Nataša Kovačić; Ivan Krešimir Lukić; Vedran Velagić; Frane Grubišić; Ana Marušić; Danka Grčević
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

3.  Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis.

Authors:  Michael M Ward; John D Reveille; Thomas J Learch; John C Davis; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2008-06-15

4.  Relationship between spinal mobility measures and quality of life in patients with ankylosing spondylitis.

Authors:  Vladislava Vesović-Potić; Dusan Mustur; Dejana Stanisavljević; Tatjana Ille; Mihailo Ille
Journal:  Rheumatol Int       Date:  2009-01-27       Impact factor: 2.631

5.  The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis.

Authors:  Thomas Hyphantis; Konstantinos Kotsis; Niki Tsifetaki; Francis Creed; Alexandros A Drosos; André F Carvalho; Paraskevi V Voulgari
Journal:  Clin Rheumatol       Date:  2013-01-18       Impact factor: 2.980

6.  Periodontal condition is associated with disease duration and motoric disabilities in patients with ankylosing spondylitis: results of a cross-sectional study.

Authors:  Dirk Ziebolz; David Douglas; Donya Douglas; Jan Schmickler; Daniel Patschan; Gerhard A Müller; Rainer Haak; Jana Schmidt; Gerhard Schmalz; Susann Patschan
Journal:  Rheumatol Int       Date:  2018-03-20       Impact factor: 2.631

7.  High frequencies of HLA-B27 in Chinese patients with suspected of ankylosing spondylitis.

Authors:  Xiang Liu; Yi-Rong Li; Li-Hua Hu; Zhi-Ming Zhou; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-09-23       Impact factor: 2.631

8.  Patients with ankylosing spondylitis have increased sick leave--a registry-based case-control study over 7 yrs.

Authors:  Britta Strömbeck; Lennart T H Jacobsson; Ann Bremander; Martin Englund; Anders Heide; Aleksandra Turkiewicz; Ingemar F Petersson
Journal:  Rheumatology (Oxford)       Date:  2009-01-22       Impact factor: 7.580

9.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.

Authors:  Fausto Salaffi; Marina Carotti; Stefania Gasparini; Michele Intorcia; Walter Grassi
Journal:  Health Qual Life Outcomes       Date:  2009-03-18       Impact factor: 3.186

10.  Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis.

Authors:  Désirée M van der Heijde; Dennis A Revicki; Katherine L Gooch; Robert L Wong; Hartmut Kupper; Neesha Harnam; Chris Thompson; Joachim Sieper
Journal:  Arthritis Res Ther       Date:  2009-08-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.